Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)

This study has been completed.
Information provided by (Responsible Party):
PETHEMA Foundation Identifier:
First received: July 19, 2007
Last updated: October 27, 2014
Last verified: October 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2014
  Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)